Kerlys G. Correoso-Braña

Kerlys G. Correoso-Braña

Auto-generated profile, based on publicly available information

Kerlys G. Correoso-Braña

Department of Cell Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
Ana Lilia Moreno SalinasAna Lilia Moreno Salinas
Ana Lilia Moreno Salinas
BHBrian J. Holleran
Brian J. Holleran
EOEstefania Y. Ojeda-Muñiz
Estefania Y. Ojeda-Muñiz
KCKerlys G. Correoso-Braña
Kerlys G. Correoso-Braña
SRSheila Ribalta-Mena
Sheila Ribalta-Mena
ABAntony A. Boucard
Antony A. Boucard
Latrophilin-3 (Lphn3; also known as ADGRL3) is a member of the adhesion G Protein Coupled Receptor subfamily, which participates in the stabilization and maintenance of neuronal networks by mediating intercellular adhesion through heterophilic interactions with transmembrane ligands. Polymorphisms modifying the Lphn3 gene are associated with attention-deficit/hyperactivity disorder (ADHD) in children and its persistence into adulthood. How these genetic alterations affect receptor function remains unknown. Here, we conducted the functional validation of distinct ADHD-related Lphn3 variants bearing mutations in the receptor’s adhesion motif-containing extracellular region. We found that all variants tested disrupted the ability of Lphn3 to stabilize intercellular adhesion in a manner that was distinct between ligands classes, but which did not depend on ligand-receptor interaction parameters, thus pointing to altered intrinsic receptor signaling properties. Using G protein signaling biosensors, we determined that Lphn3 couples to Gαi1, Gαi2, Gαs, Gαq, and Gα13. However, all ADHD-related receptor variants consistently lacked intrinsic as well as ligand-dependent Gα13 coupling efficiency while maintaining unaltered coupling to Gαi, Gαs, and Gαq. Consistent with these alterations, actin remodeling functions as well as actin-relevant RhoA signaling normally displayed by the constitutively active Lphn3 receptor were impeded by select receptor variants, thus supporting additional signaling defects. Taken together, our data point to Gα13 selective signaling impairments as representing a disease-relevant pathogenicity pathway that can be inherited through Lphn3 gene polymorphisms. This study highlights the intricate interplay between Lphn3 GPCR functions and the actin cytoskeleton in modulating neurodevelopmental cues related to ADHD etiology.

1 August 2023 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
EOEstefania Y. Ojeda‐Muñiz
Estefania Y. Ojeda‐Muñiz
BRBrenda Rodríguez‐Hernández
Brenda Rodríguez‐Hernández
KCKerlys G. Correoso‐Braña
Kerlys G. Correoso‐Braña
PSPetra L. Segura‐Landa
Petra L. Segura‐Landa
ABAntony A. Boucard
Antony A. Boucard
Adhesion G protein‐coupled receptors (aGPCRs) possess a unique topology, including the presence of a GPCR proteolysis site (GPS), which, upon autoproteolysis, generates two functionally distinct fragments that remain non‐covalently associated at the plasma membrane. A proposed activation mechanism for aGPCRs involves the exposure of a tethered agonist, which depends on cleavage at the GPS. However, this hypothesis has been challenged by the observation that non‐cleavable aGPCRs exhibit constitutive activity, thus making the function of GPS cleavage widely enigmatic. In this study, we sought to elucidate the function of GPS‐mediated cleavage through the study of G protein coupling with Latrophilin‐3/ADGRL3, a prototypical aGPCR involved in synapse formation and function. Using BRET‐based G protein biosensors, we reveal that an autoproteolysis‐deficient mutant of ADGRL3 retains constitutive activity. Surprisingly, we uncover that cleavage deficiency leads to a signalling bias directed at potentiating the activity of select G proteins such as Gi2 and G12/13. These data unveil the underpinnings of biased signalling for aGPCRs defined by GPS autoproteolysis.

5 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KCKerlys G. Correoso-Braña
Kerlys G. Correoso-Braña
AAAugusto Anesio
Augusto Anesio
SDSylvie Dumas
Sylvie Dumas
EVEmmanuel Valjent
Emmanuel Valjent
NHNicolas Heck
Nicolas Heck
ABAntony A. Boucard
Antony A. Boucard
Comorbidity between psychiatric traits is thought to involve overlapping pleiotropic effects from sets of genes. Notably, substance abuse is a shared comorbid condition among various neurodevelopmental disorders with externalizing symptoms such as autism spectrum disorder and attention-deficit hyperactivity disorder, thus hinting at the nucleus accumbens (NAc) as a site for predisposition underlying convergence of genetic influences in reward-related comorbidity. Here, we identify the autism-related gene encoding the adhesion G protein-coupled receptor (aGPCR) Latrophilin-1/ADGRL1 as an essential transducer of reward mechanisms in the NAc. We found that ADGRL1 mRNA is ubiquitously expressed throughout major NAc neuronal populations in mice. A mouse model of pan-neuronal Adgrl1 deficiency in the NAc displayed cocaine-seeking impairments in adult individuals denoting its role in drug-induced reinforcement and reward. Connecting molecular pathways of cocaine-induced learning, we uncover that ADGRL1 constitutes a functional receptor for autism-related cocaine effector molecule hevin/SPARCL1. Indeed, hevin interacts with membrane-expressed ADGRL1 and induces its internalization while stabilizing its uncleaved fraction. Moreover, hevin alters the formation of intercellular adhesion contacts mediated by ADGRL1 and Neurexin-1. Importantly, the functional constitutive coupling between ADGRL1 and various G protein pathways is selectively modulated by hevin stimulation with a bias toward Gi3, Gs, and G13 proteins. These findings unveil the dual role of ADGRL1 and hevin as genetic risk factors for both psychiatric disorders and substance abuse to define the molecular etiology of comorbidity.